DrugPatentWatch Database Preview
Hikma Company Profile
» See Plans and Pricing
What is the competitive landscape for HIKMA, and when can generic versions of HIKMA drugs launch?
HIKMA has three hundred and fifty-three approved drugs.
There are five US patents protecting HIKMA drugs. There are three tentative approvals on HIKMA drugs.
Summary for Hikma
| US Patents: | 5 |
| Tradenames: | 247 |
| Ingredients: | 227 |
| NDAs: | 353 |
| Patent Litigation for Hikma: | See patent lawsuits for Hikma |
| PTAB Cases with Hikma as petitioner: | See PTAB cases with Hikma as petitioner |
Drugs and US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma Intl Pharms | ISOSORBIDE DINITRATE | isosorbide dinitrate | TABLET;ORAL | 088088-001 | Nov 2, 1987 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | ICOSAPENT ETHYL | icosapent ethyl | CAPSULE;ORAL | 209457-001 | May 21, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-002 | Apr 16, 2010 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | ETOMIDATE | etomidate | INJECTABLE;INJECTION | 202354-001 | Feb 25, 2016 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | LEVOMILNACIPRAN HYDROCHLORIDE | levomilnacipran hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 210732-004 | Nov 5, 2020 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Hikma | SODIUM POLYSTYRENE SULFONATE | sodium polystyrene sulfonate | SUSPENSION;ORAL, RECTAL | 089049-001 | Nov 17, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Hikma Farmaceutica | GLYCOPYRROLATE | glycopyrrolate | INJECTABLE;INJECTION | 090963-001 | Sep 21, 2011 | AP | RX | No | Yes | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hikma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-001 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| Hikma | ATIVAN | lorazepam | INJECTABLE;INJECTION | 018140-002 | Approved Prior to Jan 1, 1982 | 4,017,616 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HIKMA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 0.6 mg | ➤ Subscribe | 2016-06-10 |
| ➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
| ➤ Subscribe | Tablets | 1 mg | ➤ Subscribe | 2009-08-14 |
| ➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
